NCT02065063 2018-06-01A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Anti-Cancer Activity of Trametinib in Combination With Palbociclib in Subjects With Solid TumorsGlaxoSmithKlinePhase 1 Completed28 enrolled